You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HER2 (human epidermal growth factor receptor 2)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Invasive Trial (pyrotinib)

Not yet recruiting
  • Breast Cancer Invasive
  • (no location specified)
Jun 18, 2023

Breast Cancer Trial in Sarasota, Nashville (AC699)

Recruiting
  • Breast Cancer
  • Sarasota, Florida
  • +1 more
Jan 3, 2023

Metastatic Breast Cancer Trial in Italy (Both blood and tissues collection for patients with metastatic breast cancer HER2+

Completed
  • Metastatic Breast Cancer
  • Both blood and tissues collection for patients with metastatic breast cancer HER2+ pretreated with no more than one line of anti-HER2 therapy for advanced breast cancer.
  • Bergamo, Italy
  • +8 more
Feb 9, 2023

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab

Recruiting
  • Locally Advanced or Unresectable Metastatic Breast Cancer
  • Stage IV Breast Cancer
  • Sacituzumab Govitecan-hziy
  • +3 more
  • Marietta, Georgia
  • +1 more
Apr 21, 2023

Breast Cancer Trial (Tucatinib, Doxil)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Feb 17, 2023

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

HER-2 Expression in Pancreatic Duct Adenocarcinoma

Completed
  • Pancreatic Adenocarcinoma
  • immunohistochemical approach
  • (no location specified)
Sep 20, 2023

Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

Active, not recruiting
  • Breast Neoplasms
  • Chuo Ku, Japan
  • +1 more
Dec 19, 2022

HER2-positive Breast Cancer Trial in Tampa (biological, drug, procedure)

Recruiting
  • HER2-positive Breast Cancer
  • HER-2 pulsed DC1
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 6, 2022

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ocala, Florida
    Ocala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023

HER2-negative Metastatic Breast Cancer Trial in Paris (Chemotherapy monitoring by circulating tumor DNA analysis)

Recruiting
  • HER2-negative Metastatic Breast Cancer
  • Chemotherapy monitoring by circulating tumor DNA analysis
  • Paris, France
    Institut Curie
Oct 20, 2021

Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

Not yet recruiting
  • Breast Cancer
  • Breast Cancer, Early-Onset
  • (no location specified)
Jan 18, 2023

HER2(Human Epidermal Growth Factor Receptor 2) -Positive

Not yet recruiting
  • Breast Cancer
    • Arkhangelsk, Russian Federation
    • +27 more
    Jun 13, 2023

    Primary Breast Cancer Trial (SPECT)

    Not yet recruiting
    • Primary Breast Cancer
    • (no location specified)
    Jun 19, 2023

    Recurrent/Advanced Gastric Cancer Trial in Seoul (Chemotherapy)

    Not yet recruiting
    • Recurrent/Advanced Gastric Cancer
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Aug 22, 2022

    Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

    Not yet recruiting
    • Triple-Negative Breast Cancer
    • Trastuzumab Deruxtecan
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jul 12, 2023

    Older Women With ER Positive, HER2 Negative Early Breast Cancer

    Enrolling by invitation
    • Breast Cancer Female
    • Translational study
    • Sutton, United Kingdom
      The Royal Marsden NHS Foundation Trust
    Feb 8, 2023

    Breast Cancer Stage II Trial in Xi'an (Anlotinib)

    Recruiting
    • Breast Cancer Stage II
    • Xi'an, Shannxi Province, China
      Xijing Hospital Affiliated to Air Force Military Medical Univers
    Sep 25, 2022

    Adenocarcinoma, Gastric, Tumor, Breast Trial in Taipei (DS-8201a)

    Completed
    Has Results
    • Adenocarcinoma, Gastric
    • Neoplasm, Breast
    • Taipei, Taiwan
    • +1 more
    Nov 2, 2022

    HER2-positive Gastric Cancer Trial in Jinan, Qingdao, Yantai (Disitamab vedotin, Tislelizumab, S1)

    Not yet recruiting
    • HER2-positive Gastric Cancer
    • Disitamab vedotin
    • +2 more
    • Jinan, Shandong, China
    • +6 more
    Oct 16, 2022

    Breast Tumors, Breast Cancer, Adenocarcinomas Trial run by the NCI (AdHER2/neu DC Vaccine)

    Completed
    Has Results
    • Breast Neoplasms
    • +3 more
    • Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 12, 2022

    Breast Cancer Female Trial in Tomsk ([99mTc]Tc-G3-(G3S)3C)

    Enrolling by invitation
    • Breast Cancer Female
    • Tomsk, Russian Federation
      Olga
    Jun 19, 2023

    Advanced Breast Cancer Trial in Dallas (PD-0332991 and T-DM1)

    Completed
    • Advanced Breast Cancer
    • PD-0332991 and T-DM1
    • Dallas, Texas
      UT Southwestern Medical Center
    Jan 24, 2022

    Breast Cancer Trial in Shanghai (Pertuzumab)

    Not yet recruiting
    • Breast Cancer
    • Shanghai, Shanghai, China
      Shanghai Jiaotong University School of Medicine affiliated Ruiji
    Jun 4, 2023